Saturday 17 October 2026
Export AMTX’s income statement to Excel — free account
Aemetis, Inc
AMTX Basic Materials Specialty Chemicals
In the quarter to June 2026, revenue grew 20.0%, EPS grew 68.3%, free cash flow fell 12.5% and total debt rose 13.7%, each against the same quarter a year earlier.
1.47
0.02
+1.38%
Follow AMTX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.71 | 0.40 | 0.97 | 0.51 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
46.72 | 14.44 | (20.19) | (61.77) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.34 | 2.03 | 2.57 | 2.09 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 128.83 | |
EV/Operating CF |
(31.20) | 129.18 | (75.69) | (133.48) | |
EV/FCF |
(15.03) | (18.54) | (14.78) | (12.21) | |
Quick Ratio |
0.02 | 0.03 | 0.03 | 0.04 | |
Current Ratio |
0.05 | 0.07 | 0.09 | 0.08 | |
Net Debt/EBITDA |
(64.05) | 169.50 | (191.95) | 41.99 | |
Debt/Assets |
138.06% | 132.02% | 131.65% | 126.27% | |
Debt/Equity |
(1.09) | (1.12) | (1.11) | (1.13) | |
Asset Turnover |
0.82 | 0.80 | 0.86 | 0.87 | |
Operating CF/Net income |
(0.13) | (1.08) | 0.49 | 0.20 | |
Capex/Depreciation |
(1.20) | (3.70) | (1.45) | (2.94) | |
Interest Coverage |
(0.72) | (0.21) | (0.51) | 0.43 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.28% | 19.02% | 16.64% | 12.35% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.34% | 1.57% | 3.21% | 1.79% | |
Graham Net Nets |
(3.70) | (6.47) | (2.61) | (4.97) | |
Graham Number |
13.17 | 12.37 | 11.35 | 9.65 | |
Earnings Yield |
(71.56%) | (95.68%) | (37.30%) | (55.49%) | |
Free Cash Flow Yield |
(21.85%) | (27.27%) | (17.92%) | (33.83%) | |
Revenue per Share |
0.93 | 0.89 | 0.82 | 0.88 | |
Operating CF per Share |
0.05 | 0.10 | (0.16) | (0.03) | |
Capex per Share |
(0.06) | (0.28) | (0.10) | (0.12) | |
Free Cash Flow per Share |
(0.02) | (0.18) | (0.26) | (0.15) | |
Cash per Share |
0.09 | 0.08 | 0.07 | 0.01 | |
Shareholders Equity per Share |
(4.79) | (5.12) | (4.81) | (4.54) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(4.79) | (5.12) | (4.81) | (4.54) | |
Free Cash Flow |
(1.02) | (10.79) | (17.10) | (10.42) | |
Working Capital |
(327.81) | (344.39) | (361.56) | (382.03) | |
Capital Expenditures |
(4.09) | (16.56) | (6.55) | (8.53) | |
Net Current Asset Value |
(530.42) | (539.80) | (556.78) | (578.29) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.31 | 0.12 | 0.14 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.84 | 10.03 | 3.81 | 8.59 | |
Average Payables |
33.58 | 28.28 | 27.92 | 26.59 | |
Average Inventory |
12.28 | 18.53 | 16.66 | 13.00 | |
Average Assets |
244.27 | 259.57 | 256.42 | 264.60 | |
Average Common Equity |
(281.88) | (285.38) | (300.92) | (305.68) |
Columns are period end dates